Arcturus Therapeutics Holdings (ARCT) Total Liabilities (2018 - 2026)

Arcturus Therapeutics Holdings has reported Total Liabilities for 9 years, with the latest figure at $54.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 44.86% year-over-year to $54.0 million; the trailing twelve-month figure through Mar 2026 stood at $54.0 million (down 44.86% YoY), and the FY2025 full-year result was $57.2 million, down 44.55% from the prior year.
• Total Liabilities for Q1 2026 stood at $54.0 million, down from $57.2 million in the prior quarter.
• The five-year high for Total Liabilities was $180.1 million in Q4 2022, with the low at $54.0 million in Q1 2026.
• Historically, Total Liabilities has averaged $124.1 million across 5 years, with a median of $141.6 million in 2023.
• Annual changes were most pronounced in 2022 — Total Liabilities rose 22.02% — and 2025, when it tumbled 46.88%.
• Arcturus Therapeutics Holdings' Total Liabilities stood at $180.1 million in 2022, then fell by 16.21% to $150.9 million in 2023, then slumped by 31.68% to $103.1 million in 2024, then slumped by 44.55% to $57.2 million in 2025, then retreated by 5.45% to $54.0 million in 2026.
• The last three Total Liabilities figures came in at $54.0 million (Q1 2026), $57.2 million (Q4 2025), and $57.8 million (Q3 2025), per Business Quant data.